Growth suppression of cervical carcinoma by pigment epithelium-derived factor via anti-angiogenesis

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cancer Biology & Therapy

• Publication date

  2010-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4161/cbt.9.12.11635PMID 20364117
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytosolic phospholipase A 2 - (cid:1) is an early apoptotic activator in PEDF-induced endothelial cell apoptosis

  2009cited by this paper
• Characterization of PEDF: A multi‐functional serpin family protein

  2009cited by this paper
• Novel strategy of anti-angiogenic therapy for uterine cervical carcinomas.

  2009cited by this paper
• PEDF inhibits growth of retinoblastoma by anti‐angiogenic activity

  2009cited by this paper
• Expression of Vascular Endothelial Growth Factor and Hypoxia Inducible Factor‐1α in Cervical Neoplasia

  2009cited by this paper
• Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease.

  2008cited by this paper
• Kallikrein-binding protein inhibits growth of gastric carcinoma by reducing vascular endothelial growth factor production and angiogenesis

  2007cited by this paper
• PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells.

  2007cited by this paper
• Kallikrein-binding protein suppresses growth of hepatocellular carcinoma by anti-angiogenic activity.

  2007cited by this paper
• Clinicopathologic significance of hypoxia‐inducible factor 1α overexpression in gastric carcinomas

  2006cited by this paper
• Decreased Pigment Epithelium–Derived Factor Expression in Human Breast Cancer Progression

  2006cited by this paper
• Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells.

  2005cited by this paper
• Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.

  2005cited by this paper
• Decreased Pigment Epithelium-Derived Factor Is Associated with Metastatic Phenotype in Human and Rat Prostate Tumors

  2004cited by this paper
• Inhibition of Xenografted Human Melanoma Growth and Prevention of Metastasis Development by Dual Antiangiogenic/Antitumor Activities of Pigment Epithelium-Derived Factor

  2004cited by this paper
• Expression of Pigment Epithelium-Derived Factor Decreases Liver Metastasis and Correlates with Favorable Prognosis for Patients with Ductal Pancreatic Adenocarcinoma

  2004cited by this paper
• Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation.

  2004cited by this paper
• Antiangiogenic property of pigment epithelium‐derived factor in hepatocellular carcinoma

  2004cited by this paper
• Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.

  2003cited by this paper
• Loss of pigment epithelium derived factor expression in glioma progression

  2003cited by this paper
• Pigment epithelium–derived factor regulates the vasculature and mass of the prostate and pancreas

  2003cited by this paper
• YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.

  2003cited by this paper
• Microvessel density as a prognostic factor in preinvasive and invasive cervical lesions.

  2003cited by this paper
• Angiogenesis in health and disease

  2003cited by this paper
• Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium–derived factor

  2002cited by this paper
• Role of angiogenesis in tumor growth and metastasis.

  2002cited by this paper
• Down-regulation of Vascular Endothelial Growth Factor and Up-regulation of Pigment Epithelium-derived Factor

  2002cited by this paper
• Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor

  2001cited by this paper
• Unbalanced expression of VEGF and PEDF in ischemia‐induced retinal neovascularization

  2001cited by this paper
• Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity.

  2001cited by this paper
• Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.

  1999cited by this paper
• Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia.

  1995cited by this paper
• Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

  1991cited by this paper
• Vascular endothelial growth factor is a secreted angiogenic mitogen.

  1989cited by this paper

• The Sensitive Genes for Cervical Cancer: Two-Sample Mendelian Randomization with Experimental Validation

  2025cites this paper
• Effect of Chemotherapy on Vascularization of Cervical Cancer

  2025cites this paper
• The comparison of pathogenic role and mechanism of Kallistatin and PEDF in tumors.

  2025cites this paper
• The Various Roles of PEDF in Cancer

  2024cites this paper
• Emerging immunologic approaches as cancer anti-angiogenic therapies

  2024cites this paper
• PEDF inhibits LPS-induced acute lung injury in rats and promotes lung epithelial cell survival by upregulating PPAR-γ

  2023cites this paper
• Sonodynamic therapy suppresses matrix collagen degradation in vulnerable atherosclerotic plaque by modulating caspase 3 - PEDF/HIF-1α - MMP-2/MMP-9 signaling in macrophages

  2022influential citation
• Pigment epithelium-derived factor and its role in microvascular-related diseases.

  2022cites this paper
• Directed Evolution Enables Simultaneous Controlled Release of Multiple Therapeutic Proteins from Biopolymer‐Based Hydrogels

  2022cites this paper
• Detection of Circulating Serum Protein Biomarkers of Non-Muscle Invasive Bladder Cancer after Protein Corona-Silver Nanoparticles Analysis by SWATH-MS

  2021cites this paper
• Therapeutic Potential of Pigment Epithelium-derived Factor in Cancer.

  2019cites this paper
• Pigment epithelium‐derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol

  2018cites this paper
• Promising Nanocarriers for PEDF Gene Targeting Delivery to Cervical Cancer Cells Mediated by the Over-expressing FRα

  2016cites this paper
• Pigment epithelium-derived factor has a role in the progression of papillary thyroid carcinoma by affecting the HIF1α-VEGF signaling pathway.

  2016cites this paper
• Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors

  2016cites this paper
• Expression of pigment epithelium-derived factor is associated with a good prognosis and is correlated with epithelial-mesenchymal transition-related genes in infiltrating ductal breast carcinoma

  2015cites this paper
• Administration of Pigment Epithelium-Derived Factor Inhibits Airway Inflammation and Remodeling in Chronic OVA-Induced Mice via VEGF Suppression

  2015cites this paper
• Prognostic Value of Molecular Markers and Implication for Molecular Targeted Therapies in Nasopharyngeal Carcinoma: An Update in an Era of New Targeted Molecules Development

  2015cites this paper
• Pigment epithelium-derived factor enhances tumor response to radiation through vasculature normalization in allografted lung cancer in mice

  2015cites this paper
• Current Evidence and Potential Mechanisms of Therapeutic Action of PEDF in Cervical Cancer Treatment.

  2015cites this paper
• PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases

  2015cites this paper
• Genetic Signature of Histiocytic Sarcoma Revealed by a Sleeping Beauty Transposon Genetic Screen in Mice

  2014cites this paper
• The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential

  2013cites this paper
• The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?

  2013cites this paper
• Expression of pigment epithelium-derived factor and tumor necrosis factor-α is correlated in bladder tumor and is related to tumor angiogenesis.

  2013cites this paper
• Thrombospondin-1 and pigment epithelium-derived factor enhance responsiveness of KM12 colon tumor to metronomic cyclophosphamide but have disparate effects on tumor metastasis.

  2013cites this paper
• Pigment epithelial-derived factor expression in endometriotic lesions in a rat model of endometriosis.

  2013cites this paper
• Genetic determinants of oxidative stress‐mediated sensitization of drug‐resistant cancer cells

  2012cites this paper
• Pigment epithelium-derived factor gene loaded in cRGD-PEG-PEI suppresses colorectal cancer growth by targeting endothelial cells.

  2012cites this paper
• Gene therapy of endometriosis introduced by polymeric micelles with glycolipid-like structure.

  2012cites this paper
• Therapeutic potential of bone marrow-derived mesenchymal stem cells producing pigment epithelium-derived factor in lung carcinoma.

  2012cites this paper
• PEDF inhibits growth and invasiveness of endometrial cancer cells in vitro.

  2012cites this paper
• Regulation of MT1-MMP and MMP-2 by the Serpin PEDF: a Promising New Target for Metastatic Cancer

  2012cites this paper
• Rational Design and Development of Anti- Angiogenic Protein Agents

  2011cites this paper
• PEDF effectively decreases VEGF to PEDF messenger RNA ratio of the inner edge of rat hepatocellular carcinoma induced by diethyl nitrosamine - an "in vivo" study.

  2011cites this paper